11.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AUPH?
Forum
Prognose
Aktiensplit
Aurinia Pharmaceuticals Inc Aktie (AUPH) Neueste Nachrichten
How to escape a deep drawdown in Aurinia Pharmaceuticals Inc.July 2025 PreEarnings & Scalable Portfolio Growth Ideas - newser.com
Can Aurinia Pharmaceuticals Inc. stock reach $100 price targetTrade Entry Report & Step-by-Step Swing Trade Plans - newser.com
Does Aurinia’s Latest Share Spike Reflect Its True Value After Recent Pipeline Updates? - Yahoo Finance
Can Aurinia Pharmaceuticals Inc. (IKAP) stock reach $200 price targetTrade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com
Statistical indicators supporting Aurinia Pharmaceuticals Inc.’s strengthTrade Volume Summary & Daily Chart Pattern Signals - newser.com
Technical analysis overview for Aurinia Pharmaceuticals Inc. stockTrade Ideas & Real-Time Chart Breakout Alerts - newser.com
Real time breakdown of Aurinia Pharmaceuticals Inc. stock performance2025 Top Decliners & AI Based Buy and Sell Signals - newser.com
What the charts say about Aurinia Pharmaceuticals Inc. todayRate Hike & Daily Stock Trend Reports - newser.com
Market reaction to Aurinia Pharmaceuticals Inc.’s recent newsWeekly Market Report & Risk Controlled Swing Alerts - newser.com
Predicting Aurinia Pharmaceuticals Inc. trend using moving averages2025 Geopolitical Influence & Weekly High Momentum Picks - newser.com
Aurinia Pharmaceuticals' (AUPH) "Hold (C)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Analyzing net buyer seller activity in Aurinia Pharmaceuticals Inc.2025 Fundamental Recap & Free Community Consensus Stock Picks - newser.com
Can trapped investors hope for a rebound in Aurinia Pharmaceuticals Inc.Weekly Profit Recap & Fast Moving Stock Trade Plans - newser.com
Combining machine learning predictions for Aurinia Pharmaceuticals Inc.Portfolio Return Report & Stock Portfolio Risk Management - newser.com
Will Aurinia Pharmaceuticals Inc. price bounce be sustainableMarket Risk Summary & Proven Capital Preservation Methods - newser.com
Is Shriram Asset Management Company Limited a Hybrid Growth Value Stock Worth HoldingPrice Gap Trading Strategies & Achieve Triple Digit Returns - earlytimes.in
Aurinia Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
How Aurinia Pharmaceuticals Inc. (IKAP) stock compares with top peers2025 Short Interest & Community Consensus Picks - newser.com
Pattern recognition hints at Aurinia Pharmaceuticals Inc. upsidePortfolio Update Report & Proven Capital Preservation Methods - newser.com
Using AI based signals to follow Aurinia Pharmaceuticals Inc.July 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
Forecasting Aurinia Pharmaceuticals Inc. price range with options dataQuarterly Market Review & High Return Trade Opportunity Guides - newser.com
Could Regulatory Scrutiny Shift the Risk Profile for Aurinia Pharmaceuticals (AUPH)? - Sahm
How high can Aurinia Pharmaceuticals Inc. stock go2025 Momentum Check & High Accuracy Investment Signals - newser.com
Smart tools for monitoring Aurinia Pharmaceuticals Inc.’s price actionGap Up & Verified Stock Trade Ideas - newser.com
Aurinia Pharma Surges Pre-Market After Director Kevin Tang Discloses $10M Stock Buy: Retail Confidence Spikes - MSN
TD Cowen Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $11 - 富途牛牛
Aurinia Pharmaceuticals Hits Day Low of $11.04 Amid Price Pressure - Markets Mojo
Aurinia responds after top FDA official’s comment on lead drug - MSN
Aurinia Sinks After FDA Official Questions Its Drug in Post - MSN
FDA official’s comments spark Aurinia sell-off; Halozyme buys a biotech - BioPharma Dive
Why retail investors pile into Aurinia Pharmaceuticals Inc. stock2025 Key Lessons & Technical Pattern Based Signals - newser.com
Can swing trading help recover from Aurinia Pharmaceuticals Inc. lossesJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Will earnings trigger a reversal in Aurinia Pharmaceuticals Inc.Market Trend Review & Smart Investment Allocation Insights - newser.com
What analysts say about Aurinia Pharmaceuticals Inc stockEconomic Impact on Stocks & Double Digit Profit Strategies - earlytimes.in
Aurinia Defends Benefit/Risk Profile of Lupus Nephritis Treatment After FDA Official's Retracted LinkedIn Post - MarketScreener
Aurinia Pharma rises after defending lupus drug - TradingView
Aurinia Sinks After FDA Official Questions Its Drug on LinkedIn - Bloomberg.com
Aurinia Pharma Stands By Lupus Drug After FDA Official’s Retracted Post Sparks 16% Selloff — Retail Stays Bullish On Recovery - MSN
Jefferies reiterates Hold rating on Aurinia Pharmaceuticals stock at $10 price target - Investing.com Canada
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):